Faculty who have authored publication Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
| Name | Title | Department | Institution |
|---|---|---|---|
| Mehdi H. Hamadani MD | Professor | Medicine | Medical College of Wisconsin |
